Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition

上皮ROS信号在介导心理应激引起的粘膜功能障碍和结肠炎易感性中的作用

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT: Inflammatory bowel diseases (IBD) are becoming more prevalent in the US and represent a major societal health concern. Exposure to psychosocial stressors increases the likelihood of developing IBD in genetically predisposed individuals, implicating a brain-gut axis in the IBD etiological framework. An emerging line of work has established that stress-induced disruptions to the gut microbiota (i.e. dysbiosis) may be the most proximate cause of stress-induced IBD predisposition. This includes data from our laboratory where we showed that a mouse adaptive pathogen (C. rodentium) was more effective at colonizing and inducing colitis in mice colonized by a microbiota from mice exposed to a chronic social defeat stressor. Moreover, our new preliminary data provides evidence stress exacerbates chronic, immune mediated (T-cell) colitis. However, how the gut microbiota and mucosal layer becomes dysregulated in response to stressors and why those changes predispose worsened colitis, is not yet understood. We recently demonstrated that stress induces large shifts in intestinal epithelial cell (IEC) activity that tightly corresponded to changes in gut microbiota function and thinning of the mucus layer. Of those changes observed in IECs, our preliminary data indicate that the reactive-oxygen species (ROS)-generating capacity of IECs may be the most proximate causes of stress-induced dysbiosis and mucosal disruption. Signs of stress in IECs were absent in germ-free (GF) mice at baseline, thus implicating the microbiota in IEC responsiveness. Nevertheless, IECs were still primed to respond differentially to an ex vivo bacterial challenge (evidenced by an increased expression in the ROS-generating enzyme dual oxidase (DUOX2), suggesting that host stress signaling molecules and the gut microbiota are together involved in regulating IEC activity. Intriguingly, the upregulation in DUOX2 and ROS activity in IECs corresponded to expansion of ROS-resistant bacteria that are capable of mucus degradation. These data led us to build a cohesive framework underlying this proposal, whereby stress hormones ‘prime’ IECs to respond to endogenous microbiota signaling/adhesion through heightened ROS generation. This enhanced ROS activity at the mucosal interface creates a unique niche for mucosal associated microbes that are resistant to ROS activity and survive by degrading mucus glycans that normally provide a barrier against both endogenous microbes and pathogens. We hypothesize that this IEC-directed expansion of ROS-resistant, mucus-degrading endogenous microbes is what underlies IBD susceptibility in organisms exposed to chronic, unabated stress.
项目摘要/摘要: 在美国,炎症性肠病(IBD)变得越来越普遍,代表了主要的社会健康 忧虑。暴露于社会心理压力源增加了开发IBD的可能性 诱发的个体,在IBD病因框架中暗示了脑肠轴。新兴的工作 已经确定应力引起的肠道菌群中断(即营养不良)可能是最近端的 压力引起的IBD倾向的原因。这包括来自我们实验室的数据,我们表明 小鼠自适应病原体(C. rodentium)在定植的小鼠定殖和诱导结肠炎方面更有效 由暴露于慢性社会失败压力源的小鼠的微生物群。而且,我们的新初步数据 提供证据应力加剧慢性,免疫介导的(T细胞)结肠炎。但是,肠道如何 微生物群和粘膜层因应激源而失调,以及这些变化的原因 尚未了解易感性结肠炎。我们最近证明,压力会引起大幅变化 肠上皮细胞(IEC)活性与肠道菌群功能的变化紧密相对应 粘液层。在IEC中观察到的这些变化中,我们的初步数据表明反应性氧 IEC的物种(ROS)生成能力可能是压力引起的营养不良的最直接原因 粘膜破坏。在基线时,无菌(GF)小鼠中没有IEC的压力迹象,因此隐含 IEC反应性中的微生物群。然而,IEC仍被启示以对离体的反应不同 细菌挑战(通过在ROS-生成酶双重氧化酶中表达增加证明 (Duox2),表明宿主应力信号分子和肠道菌群都参与 调节IEC活动。有趣的是,IEC中DUOX2和ROS活性的上调与 能够降解粘液的抗ROS抗性细菌的膨胀。这些数据导致我们构建 该提案的基础框架的凝聚力框架,在该框架中,强调荷尔蒙“ Prime” IEC对内源性做出反应 微生物群信号传导/粘附通过增强的ROS产生。这种增强的ROS活性在粘膜下 界面为抗粘膜相关的微生物创建了一个独特的利基市场,该微生物对ROS活性和生存具有抗性 通过降解通常为内源性微生物和病原体提供障碍的粘液聚糖。 我们假设这种IEC指导的ROS抗粘液内源性微生物的膨胀是 IBD易感性的基础是暴露于慢性,不减压的生物体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jacob Matthew Allen其他文献

Jacob Matthew Allen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jacob Matthew Allen', 18)}}的其他基金

Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition
上皮ROS信号在介导心理应激引起的粘膜功能障碍和结肠炎易感性中的作用
  • 批准号:
    10521707
  • 财政年份:
    2022
  • 资助金额:
    $ 66.56万
  • 项目类别:

相似国自然基金

载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
  • 批准号:
    82370515
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
  • 批准号:
    32301204
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
  • 批准号:
    82360301
  • 批准年份:
    2023
  • 资助金额:
    31 万元
  • 项目类别:
    地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
  • 批准号:
    82302691
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
  • 批准号:
    82374466
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition
上皮ROS信号在介导心理应激引起的粘膜功能障碍和结肠炎易感性中的作用
  • 批准号:
    10521707
  • 财政年份:
    2022
  • 资助金额:
    $ 66.56万
  • 项目类别:
Development of zafirlukast derivatives against Porphyromonas gingivalis
抗牙龈卟啉单胞菌的扎鲁司特衍生物的开发
  • 批准号:
    10224464
  • 财政年份:
    2021
  • 资助金额:
    $ 66.56万
  • 项目类别:
Regulation in Fusobacterium-mediated coaggregation
梭杆菌介导的共聚集的调节
  • 批准号:
    10277533
  • 财政年份:
    2021
  • 资助金额:
    $ 66.56万
  • 项目类别:
Regulation in Fusobacterium-mediated coaggregation
梭杆菌介导的共聚集的调节
  • 批准号:
    10426339
  • 财政年份:
    2021
  • 资助金额:
    $ 66.56万
  • 项目类别:
Development of zafirlukast derivatives against Porphyromonas gingivalis
抗牙龈卟啉单胞菌的扎鲁司特衍生物的开发
  • 批准号:
    10335152
  • 财政年份:
    2021
  • 资助金额:
    $ 66.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了